SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Paludan Merete)
 

Sökning: WFRF:(Paludan Merete) > (2008) > Stereotactic body r...

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.

Baumann, Pia (författare)
Karolinska Institutet,Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden
Nyman, Jan, 1956 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences,Department of Oncology and Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden
Hoyer, Morten (författare)
Divisions of Oncology and Medical Physics, Aarhus University Hospital, Denmark
visa fler...
Gagliardi, Giovanna (författare)
Karolinska Institutet,Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden
Lax, Ingmar (författare)
Karolinska Institutet,Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden
Wennberg, Berit (författare)
Karolinska Institutet,Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden
Drugge, Ninni (författare)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences,Department of Oncology and Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden
Ekberg, Lars (författare)
Divisions of Oncology, Hospital Physics, Malmö University Hospital, Sweden
Friesland, Signe (författare)
Karolinska Institutet,Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden
Johansson, Karl-Axel (författare)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences,Department of Oncology and Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden
Lund, Jo-Smund (författare)
Morhed, Elisabeth (författare)
Department of Oncology and Radiotherapy, Akademiska University Hospital, Uppsala, Sweden
Nilsson, Kristina (författare)
Uppsala universitet,Enheten för onkologi,Department of Oncology and Radiotherapy, Akademiska University Hospital, Uppsala, Sweden
Levin, Nina (författare)
Department of Oncology, Trondheim University Hospital, Norway
Paludan, Merete (författare)
Divisions of Oncology and Medical Physics, Aarhus University Hospital, Denmark
Sederholm, Christer (författare)
Östergötlands Läns Landsting,Linköpings universitet,Hälsouniversitetet,Lungmedicin,Lungmedicinska kliniken US
Traberg, Anders (författare)
Divisions of Oncology and Medical Physics, Aarhus University Hospital, Denmark
Wittgren, Lena (författare)
Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine,Divisions of Oncology, Hospital Physics, Malmö University Hospital, Sweden
Lewensohn, Rolf (författare)
Karolinska Institutet,Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden
Lund, JA (författare)
Lund, J.-Å., Department of Oncology, Trondheim University Hospital, Norway
visa färre...
 (creator_code:org_t)
Elsevier BV, 2008
2008
Engelska.
Ingår i: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. - : Elsevier BV. - 0167-8140 .- 1879-0887. ; 88:3, s. 359-67
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • BACKGROUND AND AIMS: In a retrospective study using stereotactic body radiotherapy (SBRT) in medically inoperable patients with stage I NSCLC we previously reported a local control rate of 88% utilizing a median dose of 15Gyx3. This report records the toxicity encountered in a prospective phase II trial, and its relation to coexisting chronic obstructive pulmonary disease (COPD) and cardio vascular disease (CVD). MATERIAL AND METHODS: Sixty patients were entered in the study between August 2003 and September 2005. Fifty-seven patients (T1 65%, T2 35%) with a median age of 75 years (59-87 years) were evaluable. The baseline mean FEV1% was 64% and median Karnofsky index was 80. A total dose of 45Gy was delivered in three fractions at the 67% isodose of the PTV. Clinical, pulmonary and radiological evaluations were made at 6 weeks, 3, 6, 9, 12, 18, and 36 months post-SBRT. Toxicity was graded according to CTC v2.0 and performance status was graded according to the Karnofsky scale. RESULTS: At a median follow-up of 23 months, 2 patients had relapsed locally. No grade 4 or 5 toxicity was reported. Grade 3 toxicity was seen in 12 patients (21%). There was no significant decline of FEV1% during follow-up. Low grade pneumonitis developed to the same extent in the CVD 3/17 (18%) and COPD 7/40 (18%) groups. The incidence of fibrosis was 9/17 (53%) and pleural effusions was 8/17 (47%) in the CVD group compared with 13/40 (33%) and 5/40 (13%) in the COPD group. CONCLUSION: SBRT for stage I NSCLC patients who are medically inoperable because of COPD and CVD results in a favourable local control rate with a low incidence of grade 3 and no grade 4 or 5 toxicity.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Nyckelord

Aged
Aged
80 and over
Carcinoma
Non-Small-Cell Lung
pathology
physiopathology
radiotherapy
Cardiovascular Diseases
complications
Chi-Square Distribution
Dose Fractionation
Female
Humans
Lung Neoplasms
pathology
physiopathology
radiotherapy
Male
Middle Aged
Neoplasm Staging
Prospective Studies
Pulmonary Disease
Chronic Obstructive
complications
Radiosurgery
methods
Radiotherapy Dosage
Respiratory Function Tests
Retrospective Studies
Treatment Outcome
COPD
SBRT
Inoperable stage I NSCLC
CVD
MEDICINE

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy